Mark Swanson, MD

Associate Professor of Clinical Otolaryngology-Head and Neck Surgery

Image of Mark Swanson, MD
Is this your profile? Click to edit

Overview

Mark Swanson, MD is a fellowship trained head and neck surgeon. After completing medical school at the Ohio State University, he entered a residency in Otolaryngology at University of Southern California. He continued his training with a fellowship in cancer and reconstructive surgery at the University of Miami, and returned to USC to join the faculty at Keck Medical Center. His expertise is in treatment of benign and malignant tumors of the mouth, throat, salivary glands, neck, and thyroid gland. He utilizes advanced robotic, organ preservation, and microvascular reconstructive techniques to maximize quality of life after treatment.

Dr. Swanson works in a multi-disciplinary team including surgeons, radiation oncologists, medical oncologists, and speech/swallow therapists to provide complete care for head and neck diseases.

In addition to treating patients, Dr. Swanson has a research interest in oncologic and quality of life outcomes in head and neck cancers. He focuses on swallowing and voice outcomes after cancer treatments, and is working to provide optimal cancer outcomes while preserving unaffected tissues.

Otolaryngology

Awards

  • University of Miami: Otolaryngology Fellow Teaching Award, 2016-2017
  • University of Southern California: Cancer Prevention and Early Detection Community Service Grant, 2014-2015
  • The Ohio State University: Outstanding Academic Merit, 2009-2010
  • The Ohio State University: Landachre Research Honors Society, 2008-2009
  • The Ohio State University: Alpha Omega Alpha Honor Society, 2007-2011

Publications

  • Evaluation of Oropharyngeal Cancer Information from Revolutionary Artificial Intelligence Chatbot Laryngoscope. 2024 May; 134(5):2252-2257. . View in PubMed
  • Comparison of Free Flap Outcomes at a University Hospital versus County Hospital Setting for Head and Neck Reconstruction Int Arch Otorhinolaryngol. 2023 Apr; 27(2):e183-e190. . View in PubMed
  • Opioid Sparing Multimodal Analgesia for Transoral Robotic Surgery: Improved Analgesia and Narcotic Use Reduction OTO Open. 2023 Jan-Mar; 7(1):e17. . View in PubMed
  • Human papillomavirus detection in oral rinses and history of tonsillectomy in US. adults. Am J Otolaryngol. 2022 Nov-Dec; 43(6):103558. . View in PubMed
  • Association Between Insurance Type and Outcomes of Reconstructive Head and Neck Cancer Surgery Laryngoscope. 2022 10; 132(10):1946-1952. . View in PubMed
  • 18FDG-PET/CT Specificity for the Detection of Lymphoma Recurrence in the Tonsils OTO Open. 2021 Oct-Dec; 5(4):2473974X211059081. . View in PubMed
  • Outcomes of Combined Antegrade-Retrograde Dilations for Radiation-Induced Esophageal Strictures in Head and Neck Cancer Patients Dysphagia. 2021 12; 36(6):1040-1047. . View in PubMed
  • Surgeon practice patterns in transoral robotic surgery for HPV-related oropharyngeal cancer Oral Oncol. 2021 10; 121:105460. . View in PubMed
  • Prevalence of oral human papillomavirus infections by race in the United States: An association with sexual behavior Oral Dis. 2020 Jul; 26(5):930-940. . View in PubMed
  • Association of Race/Ethnicity, Stage, and Survival in Oral Cavity Squamous Cell Carcinoma: A SEER Study OTO Open. 2019 Oct-Dec; 3(4):2473974X19891126. . View in PubMed
  • Outcomes of Self-Esophageal Dilation for Head and Neck Cancer Patients Am J Speech Lang Pathol. 2019 08 09; 28(3):1060-1066. . View in PubMed
  • Transoral surgery vs intensity-modulated radiotherapy for early supraglottic cancer: a systematic review Curr Opin Otolaryngol Head Neck Surg. 2017 Apr; 25(2):133-141. . View in PubMed
  • The Role of HPV in Head and Neck Cancer Stem Cell Formation and Tumorigenesis Cancers (Basel). 2016 Feb 19; 8(2). . View in PubMed
  • ABCLOVE: Voice therapy outcomes for patients with head and neck cancer Head Neck. 2016 04; 38 Suppl 1:E1810-3. . View in PubMed
  • Use of Octreotide for the Management of Chyle Fistula Following Neck Dissection JAMA Otolaryngol Head Neck Surg. 2015 Aug; 141(8):723-7. . View in PubMed
  • Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer—review of current data Oral Oncol. 2015 Jan; 51(1):12-5. . View in PubMed
  • Diagnosis and management of merkel cell carcinoma of the head and neck: current trends and controversies Cancers (Basel). 2014 Jun 27; 6(3):1256-66. . View in PubMed